Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

589
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
589
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

552
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
552
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

575
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
575
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

586
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
586
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

859
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
859
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

469
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
469

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TAVR in a Small Surgical Bioprosthesis With a Kinked Aortic Graft Using an Intra-Annular Self-Expanding Valve.

JACC. Case reports·2026
Same author

Sex differences in reverse remodeling after transcatheter aortic valve replacement in low-flow aortic stenosis.

The Journal of invasive cardiology·2026
Same author

Neutrophil-to-lymphocyte ratio in patients with low-flow aortic stenosis undergoing transcatheter aortic valve implantation.

Journal of cardiology·2026
Same author

Flow State after Transcatheter Aortic Valve Replacement in Low-Flow Severe Aortic Stenosis: Predictors and Outcomes Across Valve Types.

The American journal of cardiology·2026
Same author

Current Evidence, Emerging Evidence, and Decision-Making: An Algorithm for Leaflet Modification Procedures.

JACC. Cardiovascular interventions·2026
Same author

A Proposed Anatomical-Fluoroscopic Workflow to Identify the Optimal Split Line for Leaflet Modification in Redo-TAVR.

JACC. Cardiovascular interventions·2026
Same journal

Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

The American journal of the medical sciences·2026
Same journal

In Memoriam: Maurice A. Mufson, MD, MACP.

The American journal of the medical sciences·2026
Same journal

Outcomes of Acute Myeloid Leukemia Patients Admitted to the Intensive Care Unit within 100 days of Allogeneic Hematopoietic Stem Cell Transplantation.

The American journal of the medical sciences·2026
Same journal

Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

The American journal of the medical sciences·2026
Same journal

Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

The American journal of the medical sciences·2026
Same journal

The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

The American journal of the medical sciences·2026
See all related articles

Related Experiment Video

Updated: Apr 5, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

3.8K

Lipid Interventions in Aortic Valvular Disease.

Kwang Jin Choi1, Christiana Tsomidou, Stamatios Lerakis

  • 1Department of Medicine (KJC), University of Chicago Medical Center, Chicago, Illinois; Department of Medicine (CT), General Hospital of Piraeus "Hippocrates," Piraeus, Greece; Department of Medicine (SL), Emory University School of Medicine, Atlanta, Georgia; St. Francis Hospital, The Heart Center (RM, TJV), Division of Cardiology, Center for Advanced Cardiac Therapeutics, Roslyn, New York; and Zena and Michael A. Wiener Cardiovascular Institute (CEK), Icahn School of Medicine at Mount Sinai, New York, New York.

The American Journal of the Medical Sciences
|August 12, 2015
PubMed
Summary
This summary is machine-generated.

Aortic stenosis (AS) involves lipid deposition and inflammation. Lipid interventions may slow AS progression, particularly in early stages, but further research is needed to confirm effectiveness.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Related Experiment Videos

Last Updated: Apr 5, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

3.8K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Area of Science:

  • Cardiovascular Medicine
  • Valvular Heart Disease
  • Atherosclerosis Research

Background:

  • Aortic stenosis (AS) is a prevalent valvular disease in the elderly.
  • AS pathogenesis shares similarities with atherosclerosis, involving lipid deposition, inflammation, fibrosis, and calcification.
  • Current evidence on lipid interventions, like statins, for slowing AS progression is inconsistent.

Purpose of the Study:

  • To explore the potential of lipid interventions in preventing or slowing aortic stenosis progression.
  • To investigate the hypothesis that lipid interventions may be more effective in earlier stages of AS, characterized by inflammation.
  • To evaluate the utility of positron emission tomography (PET) in differentiating inflammatory and calcific components of AS.

Main Methods:

  • Review of current evidence on lipid interventions and their effect on AS progression.
  • Discussion of the role of inflammation versus calcification in AS pathogenesis.
  • Consideration of advanced imaging techniques like 18F-fluorodeoxyglucose and 18F-sodium fluoride PET scans.
  • Exploration of novel therapeutic targets such as recombinant apolipoprotein A-1 Milano and agents targeting lipoprotein (a) and lipoprotein-associated phospholipase A2.

Main Results:

  • Large clinical trials have not consistently shown statins to decrease AS progression.
  • A potential benefit of statins in early-stage AS, where inflammation predominates, is suggested.
  • Advanced AS stages are characterized by calcification, potentially limiting the efficacy of lipid-lowering therapies.
  • Novel therapeutic strategies targeting lipoprotein (a) and related enzymes are under investigation.

Conclusions:

  • Lipid interventions may hold promise for managing aortic stenosis, especially in its early, inflammatory phase.
  • Positron emission tomography imaging could help stratify patients and guide therapeutic interventions.
  • Further research into novel pharmacological agents is crucial for developing effective treatments for aortic stenosis.